Back to search

Article

JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow Transplantation

2025-09-04

Abstract excerpt

<h4>ABSTRACT</h4> Hematopoietic stem cell transplantation is a common treatment for many blood disorders and can be a life-saving therapy for patients with leukemias, lymphomas and multiple myeloma. Umbilical cord blood (UCB) serves as a valuable source of hematopoietic stem and progenitor cells (HSPCs) for transplantation, particularly for patients lacking a matched donor. However, the limited number of repopula...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ff9e0117-75b9-5f28-a49d-7d80fbf194bd
DOI
10.1101/2025.09.03.672211
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
JARID2 Inhibition Reprograms Human Hematopoietic Progenitor Cells To Enhance Bone Marrow TransplantationDOI 10.1101/2025.09.03.672211
Select a neighboring publication to make it the new centre.